留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

核辐射事故伤药物防治研究进展

刘玉明 张术 储智勇

刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
引用本文: 刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
Citation: LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.

核辐射事故伤药物防治研究进展

Advances on the medication of nuclear Radiation Accidents

  • 摘要: 随着世界各国核军备竞争的加剧,随着世界核安全形势的紧张以及核技术研究手段的不断兴起,核辐射对人类造成了极大的恐慌和伤害。如何加强核事故和核辐射损伤的应急防护和医学救治,这已经引起人们的高度重视和关注。本文针对核辐射的临床表现,从综合治疗、细胞因子、氨巯基化合物、中草药四方面,综述了目前在核事故及核辐射中药物预防与救治的研究进展,并对今后如何深入对核辐射防治药物进行开发利用进行了展望。
  • [1] Fliedner TM,Graessle D,Meineke V,et al.Pathophysiological principles underlying the blood cell concentration responses used to assess the severity of efect after accidental whole body radiation exposure:an essential basis for an evidence.based clinical triage[J].Exp Hematol,2007,35(4 Suppl 1):8.
    [2] Heimers A,Brede HJ,Giesen U,et al.Chromosome aberration analysis and the influence of mitotic delay after simulated partial-body exposure with hi gh doses uf sparsely and densely ionizing radiation[J].Radiat Environ Biophys,2006,45(1):45.
    [3] Hande MP,Azizuva TV,Burak LE,et al.Complex chromosome aberrations persist in individuals man y years after occupational exposure to densely ionizing radiation:an mF1SH study[J].Genes Chromosomes Cancer,2005,44(1):1.
    [4] Wang Y,Schulte BA,Zhou D.Hematopoietic stem cell senescence and long-term bone marrow injury[J].Cell Cycle,2006,5(1):35.
    [5] Wang Y,Schulte BA,LaRue AC,et al.Total body irradiation selectively induces murine hematopoietic stem cell senescence[J].Blood, 2006.107(1):358.
    [6] Liu YJ,Lu SH,Xu B,et al. Hemangiopoietin,a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages[J].Blood,2004,103(12):4449.
    [7] Herodin F,Drouet M.Cytokine-based treatment of accidentally irradiated victims and new approaches[J].Exp Hematol,2005,33(10),1071.
    [8] Hosseinimehr SJ, Zakaryaee V, Frouhgizaden M. Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells[J]. Mol Cell Biochem,2006,287:193.
    [9] Drouet M,Mourcin F,Grenier N,et al.Single administration of stemcell factor.FL -3 ligand.megakaryocyte growth and developmentfactor.and interleukin-3 in combination soon after irradiationprevents nonhuman primates from myelosuppression:long-term follow-up of hematopoiesis[J].Blood,2004,103(3):878.
    [10] Demirel C, Kilciksiz S, Ay OI,et al. Effect of N-acetylcysteine on radiation-induced genotoxicity and cytotoxicity in rat bone marrow[J]. Journal-of-radiation-research,2009,50(1): 43.
    [11] Demirel C, Kilciksiz S,Evirgen S,et al. The preventive effect of N-acetylcysteine on radiation-induced dermatitis in a rat model[J]. J-BUON. 2010 ,15(3): 577.
    [12] Murley J S, Kataoka Y,Baker KL,et al. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha[J]. Radiation-research,2007 ,167(4): 465.
    [13] You WC, Lin WC, Huang JT ,et al.Indigowood root extract protects hematopoietic cells reduces tissue damage and modulates inflammatory cytokines after total-body irradiation: does Indirubin play a role in radioprotection[J]. Phytomedicine,2009 ,16(12): 1105.
    [14] Liu WC, Wang SC,Tsai ML, et al.Protection against radiation-induced bone marrow and intestinal injuries by Cordyceps sinensis, a Chinese herbal medicine[J]. Radiat-Res, 2006 , 166(6): 900.
    [15] 陆兴熠 ,刘剑英,钟进义. 葡多酚对核辐射接触人员氧化损伤防护作用[J]. 中国公共卫生,2008,24(9):1072.
    [16] Goel HC, Bala M, Prasad J,et al,Radioprotection by Rhodiola imbricate in mice against whole-body lethal irradiation[J]. J Med Food. 2006 , 9(2): 154.
    [17] 梁 莉,王 婷,乔 华,等.南沙参多糖的药理作用研究进展[J]. 西北药学杂志,2008,(23) 5:334.
    [18] Li Z,Wenyi Z,Liang'an Z. General situation of radiation accidents in China[J]. Radiat Prot Dosimety,2007,124(2):177.
    [19] Weisdorf D,ChaoN,Waelenko JK,et al.Acute radiation injury:contingency planning for triage,supportive care,and transplantation[J]. Biol Blood Marrow Transplant, 2006,12(6):672.
    [20] Rencova J, Vlkova A, Vesela G. Improved chelation therapy of intramuscularly deposited horium by CaDTPA in the rat [J]. Radiat Prot Dosim, 2003, 105 : 513.
    [21] Martinez AB, Mandalunis PM, Bozal CB, et al. Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1, 1-bisphosphonate ( EHBP) [J]. Health Phys, 2003, 85(3):343.
    [22] Benkovic V, Knezevic AH, Dikic D, et al. Radioprotective effects of quercetin and ethanolic extract of propolis in gamma-irradiated mice[J]. Arh Hig Rada Toksikol, 2009 , 60(2): 129.
    [23] Srinivasan M, Devipriya N, Kalpana KB, et al. Lycopene: An antioxidant and radioprotector against gamma-radiation-induced cellular damages in cultured human lymphocytes[J]. Toxicology, 2009, 262(1): 43.
    [24] Goel A, Aggarwal BB. Curcumin the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs[J]. Nutr Cancer, 2010, 62(7): 919.
  • [1] 李锐, 张倩倩, 王瑞冬, 高小峰.  国家集中带量采购政策下样本医院良性前列腺增生治疗药物使用情况分析 . 药学实践与服务, 2025, 43(2): 1-6. doi: 10.12206/j.issn.2097-2024.202408031
    [2] 宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅.  帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
    [3] 张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英.  二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
    [4] 何亚伦, 祁智, 常杰.  消胀通便膏在晚期肝癌患者阿片类药物相关性便秘的应用研究 . 药学实践与服务, 2024, 42(12): 1-4. doi: 10.12206/j.issn.2097-2024.202309009
    [5] 夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞.  核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
    [6] 孙丹倪, 黄勇, 张嘉宝, 王培.  代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
    [7] 陈怡君, 王卓, 何苗, 张宇, 田泾.  泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
    [8] 张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一.  药物性肝损伤不良反应分析 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404034
    [9] 张元林, 宋凯, 孙蕊, 舒飞, 舒丽芯, 杨樟卫.  基于真实世界数据的药物利用研究综述 . 药学实践与服务, 2024, 42(6): 238-243. doi: 10.12206/j.issn.2097-2024.202312010
  • 加载中
计量
  • 文章访问数:  2666
  • HTML全文浏览量:  280
  • PDF下载量:  451
  • 被引次数: 0
出版历程
  • 收稿日期:  2010-11-15
  • 修回日期:  2011-04-19

核辐射事故伤药物防治研究进展

摘要: 随着世界各国核军备竞争的加剧,随着世界核安全形势的紧张以及核技术研究手段的不断兴起,核辐射对人类造成了极大的恐慌和伤害。如何加强核事故和核辐射损伤的应急防护和医学救治,这已经引起人们的高度重视和关注。本文针对核辐射的临床表现,从综合治疗、细胞因子、氨巯基化合物、中草药四方面,综述了目前在核事故及核辐射中药物预防与救治的研究进展,并对今后如何深入对核辐射防治药物进行开发利用进行了展望。

English Abstract

刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
引用本文: 刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
Citation: LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
参考文献 (24)

目录

    /

    返回文章
    返回